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Abstract
It has been previously shown that dextran sulfate administered to diabetic rats accumulates in the liver and kidney, and this
could be due to a malfunction of the lysosomal digestive pathway. The aim of the present study was to evaluate the expression
and activities of lysosomal enzymes that act upon proteins and sulfated polysaccharides in the livers of diabetic rats. Diabetes
mellitus was induced by streptozotocin in 26 male Wistar rats (12 weeks old), while 26 age-matched controls received only
vehicle. The livers were removed on either the 10th or the 30th day of the disease, weighed, and used to evaluate the activity,
expression, and localization of lysosomal enzymes. A 50-60% decrease in the specific activities of cysteine proteases,
especially cathepsin B, was observed in streptozotocin-induced diabetes mellitus. Expression (mRNA) of cathepsins B and L
was also decreased on the 10th, but not on the 30th day. Sulfatase decreased 30% on the 30th day, while glycosidases did
not vary (or presented a transitory and slight decrease). There were no apparent changes in liver morphology, and
immunohistochemistry revealed the presence of cathepsin B in hepatocyte granules. The decrease in sulfatase could be
responsible for the dextran sulfate build-up in the diabetic liver, since the action of sulfatase precedes glycosidases in the
digestive pathway of sulfated polysaccharides. Our findings suggest that the decreased activities of cathepsins resulted from
decreased expression of their genes, and not from general lysosomal failure, because the levels of glycosidases were normal
in the diabetic liver.
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Introduction
Streptozotocin-induced diabetes mellitus (STZ-DM) in
rats leads to a marked decrease in the urinary excretion of
glycosaminoglycans (1). Decreased urinary excretion of
exogenous dextran sulfate also occurs in STZ-DM, with
accumulation of dextran sulfate in liver and kidney (2).
Because dextran sulfate is very soluble in water, its
presence in liver and kidney 48 h after administration
suggests intracellular localization of these molecules.
The concentration of glycosaminoglycan also increased
in diabetic kidney (2,3), and there is evidence that both
anabolic and catabolic pathways are involved (4,5). De-
creased expression of lysosomal enzymes in diabetic kidney
was recently reported (5), and autophagy was recently pro-
posed as a therapeutic target for diabetic nephropathy (6).
Lysosomal enzymes are the main agents of the
digestive process that takes place in autophagic vacuoles
(reviewed in Ref. 7). Even though much of the pioneering
research on autophagy comes from 40 years of studies on
liver and isolated hepatocytes (8), and although lyso-
somes were discovered back in the 1950s by Christian de
Duve (9), who also maintained a lifetime interest in the
actions of insulin and glucagon on the liver (10), there are
few studies on the expression and activities of lysosomal
enzymes in the diabetic liver.
Most of the recent work on liver autophagy has focused
on lipid digestion (lipophagy) (11,12) and glycogen diges-
tion (13). There are few studies of liver lysosomal enzymes
that act upon proteins and sulfated polysaccharides. The
aim of the present study was to investigate the expression
and activities of lysosomal hydrolases in the liver of rats
with STZ-DM, in order to elucidate the mechanisms
responsible for the dextran sulfate build-up. Two different
stages of the disease were studied: 10 days (initial diabetic
state) and 30 days (diabetic nephropathy).
Correspondence: Y.M. Michelacci, Disciplina de Biologia Molecular, Departamento de Bioquı´mica, Escola Paulista de Medicina,
UNIFESP, Rua Treˆs de Maio, 100, 04044-020 Sa˜o Paulo, SP, Brasil. Fax: +55-11-5573-6407. E-mail: yara.bioq@epm.br
Present address of J.A.K. Aguiar: Departamento de Bioquı´mica, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brasil.
Received July 23, 2013. Accepted March 6, 2014. First published online May 9, 2014.
Brazilian Journal of Medical and Biological Research (2014) 47(6): 452-460, http://dx.doi.org/10.1590/1414-431X20143386
ISSN 1414-431X
Braz J Med Biol Res 47(6) 2014 www.bjournal.com.br
Material and Methods
Animals, urine, and tissue
The Ethics Committee of Escola Paulista de Medicina,
UNIFESP approved the present research (CEP No. 0170/
09), which was carried out in accordance with UNIFESP
guidelines, and also in accordance with EC Directive
2010/63/EU for animal experiments.
Male Wistar rats (n=52), 12 weeks of age (275-360 g
body weight), were randomly assigned to one of four
groups: control day 10, diabetes (DM) day 10, control day
30, and diabetes day 30. Before the induction of DM, the
animals were weighed, blood glucose was measured
(Advantage Kit Roche, Switzerland), and the animals
were placed in metabolic cages for 24-h urine collection.
Diabetes was induced in the 26 rats of DM groups by a
single intraperitoneal injection of 60 mg/kg body weight
STZ. The drug was dissolved in 300 mL 10 mM sodium
citrate buffer, pH 4.5. These animals were fed standard
laboratory chow and a 5% glucose solution ad libitum for
72 h. Afterward, the glucose solution was replaced by
water. Glycemia was measured 72 h after STZ adminis-
tration, and also at the end of each experiment (either 10th
or 30th day). Only animals that, at 72 h, presented blood
glucose higher than 250 mg/dL were considered ‘‘dia-
betic’’ (14). The 26 age-matched animals that served as
controls received only 300 mL buffer and were fed
standard laboratory chow and water ad libitum.
At the end of each experiment, body weight was again
measured, and the rats were placed in metabolic cages for
24-h urine collection. The 24-h urine volumewasmeasured
and the urine was centrifuged at 1000 g for 10 min at room
temperature to remove debris and used for determination
of creatinine, total protein, and albumin. Creatinine was
quantified by the picric acid reaction under alkaline
conditions (CELM creatinine kit, Brazil), total protein was
measured by the pyrogallol red-molybdate complex
method (Sensiprot, Labtest, Brazil) (15), and albumin was
determined by two methods: radial immunodiffusion based
on precipitation with rabbit antibodies against rat albumin
(1), and ELISA using a Bethyl E110-125 Rat Albumin
Quantification Set (USA). The results obtained for total
protein and creatinine were published in Peres et al. (5).
After the urine was collected, the rats were killed, and the
livers were removed, weighed, and carefully cut into small
fragments (,100 mg each). These fragments were used
for RNA extraction, measurement of enzyme activities,
Western blotting, and quantification of total protein. The
liver fragments were put into sterile tubes, frozen in liquid
nitrogen, and stored at –706C until use.
Liver enzyme activities
To measure the enzyme activities, liver samples
(,100 mg) were disrupted in liquid nitrogen and resus-
pended in 1 mL 50 mM Tris-HCl buffer, pH 7.4, contain-
ing 200 mM NaCl and 250 mM sucrose (16) plus 1 mL
0.2% Triton X-100. After standing for 10 min in an ice
bath, debris was removed by centrifugation (12,000 g,
10 min, 46C), and aliquots of the supernatant (100 mL)
were stored in sterile tubes at –706C until use (tissue
extracts).
Protease activities were quantified by fluorometric
assays using either carbobenzoxy-Phe-Arg-7-amide-4-
methylcoumarin (Z-FR-MCA; Sigma-Aldrich, USA) or e-
NH2-caproyl-Cys(Bzl)-Cys(Bzl)-MCA (synthesized by Prof.
Dr. Maria A. Juliano) (17) as substrates. These substrates
were used to quantify total cysteine proteases and ca-
thepsin B, respectively. Incubation was carried out in dark
microplates (Corning, USA), in 50 mM phosphate buffer,
pH 6.3, containing 10 mM EDTA. The enzymes (50 mg
protein) were preactivated by incubation of tissue extract
aliquots with 2 mM dithiothreitol (10 min, room tempera-
ture), and the substrate was then added (20 mM, 200 mL
final volume). The fluorescence produced upon hydrolysis
of the substrates was measured every 20 s in a FlexStation
3 microplate reader (Molecular Devices, USA), using
lexcitation=380 nm and lemission=460 nm. The assays
were also performed in the presence of the following
inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF;
inhibitor of serine proteases), 5 mM E64 (irreversible
inhibitor of cysteine proteases), and 1 mM CA074 (irrever-
sible inhibitor of cathepsin B).
The activities of b-D-glucuronidase, N-acetyl-b-D-glu-
cosaminidase, N-acetyl-b-D-galactosaminidase, and sul-
fatases were measured by spectrophotometric assays
using the following substrates: 4-nitrophenyl b-D-glucur-
onide, 4-nitrophenyl N-acetyl-b-D-glucosaminide, 4-nitro-
phenyl N-acetyl-b-D-galactosaminide, and 4-nitrophenyl
sulfate, respectively (Sigma-Aldrich). All assays were
performed on microplates, always as triplicates, and the
incubation mixtures (150 mL final volume) contained
50 mM sodium acetate buffer, pH 5.0, 2 mM substrate,
and increasing amounts of tissue extracts (2-30 mL
containing 20-120 mg protein). After 1 h of incubation at
room temperature, the 4-nitrophenol released was solu-
bilized by addition of 1 M NaOH (150 mL), and the
absorbance was measured immediately at l405 in a
microplate reader (Molecular Devices).
Quantification of liver protein and Western blotting
Protein was quantified in tissue extracts by a modified
Lowry procedure with bicinchoninic acid (18) (BCA
Protein Assay Kit, Thermo Scientific Pierce, USA), using
bovine serum albumin as standard.
The specificity of anti-cathepsin B and anti-b-actin
antibodies was evaluated by Western blotting (19). Tissue
extracts (1.5-2.5 mL containing 30 mg protein) were sub-
mitted to SDS-PAGE (12% acrylamide with 0.32% bisa-
crylamide for cathepsin B; 7.5% acrylamide with 0.2%
bisacrylamide for b-actin). Proteins were transferred to
nitrocellulose membranes and probed with either rabbit
polyclonal anti-cathepsin B or rabbit monoclonal anti-b-actin
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antibody. Specific bands were detected by secondary
antibody (anti-rabbit IgG) conjugated with horseradish
peroxidase (HRP) and enhanced chemiluminescence
(ECL) substrate. Images were obtained with the MF-
ChemiBIS gel documentation system, where each lane
represents a pool of four animals for each group.
Color images (tetramethylbenzidine; KPL, USA) and
chemiluminescence images (ECL Advance Western
Blotting Detection Kit; GE Healthcare, USA) were
obtained with the MF-ChemiBIS gel documentation
system (DNR Bio Imaging Systems Ltd., Israel) with the
GelCapture 7.0.6 software for WindowsTM.
RNA extraction and real-time reverse transcriptase-
polymerase chain reaction (PCR)
Each liver fragment (,100 mg) was disrupted in liquid
nitrogen, homogenized in 1 mL QIAzol Lysis Reagent
(QIAGEN, USA), and processed according to the manu-
facturer’s instructions. Absorbances (A260/280 and A260/230)
were measured (ND-1000, NanoDrop, USA), and samples
with ratios lower than 1.8 and 1.7, respectively, were
discarded. RNA integrity was also evaluated from 28S and
18S rRNA bands after agarose gel electrophoresis using
Tris-borate-EDTA buffer, as previously described (20,21).
To avoid contamination with genomic DNA, RNA samples
were treated with DNase I (1 U/mg RNA, 30 min, 376C;
Fermentas International, Canada) followed by 25 mM
EDTA (1 mL/enzyme unit, 10 min, 656C) to inactivate the
DNase I.
One microgram of RNA was reverse-transcribed to
complementary DNA (cDNA) with RevertAid M-MuLV
(Fermentas International), and the resulting single-strand
cDNA was amplified by quantitative PCR (qPCR) in a
reaction mixture containing 0.4 mM of each primer and
7.5 mL SYBR Green (15 mL final volume; Rotor-Gene
SYBR Green PCR Kit, QIAGEN). The thermal cycling
conditions were as follows: initial 5 min at 956C, followed
by 40-45 cycles of denaturing at 956C for 5 s, annealing at
606C for 10 s, and extension at 956C for 10 min. Cycle
number and cDNA concentration were adjusted so that
amplified products remained within the linear range of the
PCR. PCR amplification was conducted on a Corbett
Rotor-Gene 6000 (QIAGEN). Each PCR was done in
duplicate.
Relative gene expression was calculated by the 2–DDCT
method developed by Livak and Schmittgen (22). In this
method, it is assumed that the expression of a reference
gene (housekeeping gene) is independent of external
factors and that its expression is quite constant. In the
present paper, two genes were used as references:
ribosomal protein 29S (RPS29) and b-actin (ACTB). Other
genes were tested, but they varied in the diabetic liver,
compared with controls, and therefore were not used. The
PCR primers (Bioneer Corp., USA) are shown in Table 1.
Histology and immunohistochemistry
For histology and immunohistochemistry, one rat in
each group was anesthetized with 10% chloral hydrate
(4 mL/kg body weight) and perfused with filtered saline
(150 mL, 12 mL/min) followed by 4% formalin in 0.1 M
phosphate buffer, pH 7.4 (500 mL, 12 mL/min). The liver
was removed, cut, dehydrated, embedded in paraffin, and
cut in 4-mm sections. These sections were transferred to
silane-coated microscope slides and dewaxed as pre-
viously described (23).
Liver sections were stained with either hematoxylin
and eosin or toluidine blue, and images were obtained
with a Zeiss Axiolab microscope (Carl Zeiss MicroImaging
GmbH, Germany), equipped with an AxioCam MRc digital
camera and AxioVision software.
For immunohistochemistry, the dewaxed slides were
transferred to 200 mL prewarmed 10 mM sodium citrate
buffer, pH 6.0 (956C). Antigen retrieval was 30 min at
956C, 20 min on the bench, and 5 min under running
water. Endogenous peroxidase was blocked by 3%
hydrogen peroxide (10 min, 10 times), followed by running
water (10 min) and phosphate-buffered saline (PBS;
3 min, 3 times). Nonspecific protein binding was blocked
by 200 mL 1% bovine serum albumin (Cat. #A3059,
Sigma-Aldrich) and 2% fetal calf serum in a moist chamber
at room temperature. The primary antibody was rabbit anti-
cathepsin B (Cat. #06-480; EMD Millipore, USA) diluted
1:100 in blocking solution. After an overnight incubation at
46C and three 5-min washes in PBS, HRP-conjugated goat
anti-rabbit IgG, secondary antibody (Cat. #12-348, EMD
Millipore) diluted 1:200 in blocking solution was added.
After a 90-min incubation and three 5-min washes in PBS,
nickel-enhanced diaminobenzidine (Cat. #54-74-00,
HistoMark Orange Peroxidase System; KPL) was used
as HRP substrate. Then, the tissue sections were rinsed
under running water and counterstained by Harris modified
hematoxylin solution (Cat. #HHS16, Sigma-Aldrich) for
Table 1. PCR primers.
Enzyme Forward Reverse
Cathepsin B 59-GCTATCCCTCTGGAGCATGGAAC-39 59-GACGGGAGCCATTGACATGGT-39
Cathepsin L 59-AGGCAATCAGGGCTGTAATGGAG-39 59-CGTTAGCCACAGCATACTCAGCTC-39
b-D-glucuronidase 59-CAGTGCTTCCACAGCGATGGA-39 59-GTGATGTCAGCCTCAAAGGGGAG-39
b-actin 59-GGATGACGATATCGCTGCGCT-39 59-CTGACCCATACCCACCATCACAC-39
Ribosomal protein S29 59-GTCAGTACGCGAAGGACATAGGC-39 59-CAGGGTAGACAGTTGGTTTCATTGGG-39
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30 s. Excess hematoxylin was removed by 0.1% HCl in
70% ethanol, followed by a 5-min rinse under running
water. Slides were dehydrated and mounted in Entellan
(Cat. #14800, Merck, Germany) and sealed with clear nail
polish. Negative controls were incubated with blocking
solution at each step.
Statistical analysis
Statistical analysis was performed with the PASW
Statistics software (SPSS Statistics) for WindowsTM
(version 18.0.0). The Shapiro-Wilk test was used to
evaluate data for normality, and data were standardized
(z-score) when the parametric distribution was not
observed. Bootstrap (a resampling method) was also
used to check for the stability of the experimental data.
Results are reported as means±SD, except for enzyme
kinetics, when means±95% confidence interval are
reported. Differences between groups were analyzed by
ANOVA. Values of P,0.05 were considered to be
significant, except where otherwise stated.
Results
Glycemia, albuminuria, and liver weight
The body weight of the animals at the beginning (day
zero) and at the end (either 10th or 30th day) of the ex-
periment, glycemia, urine volume, albuminuria, and liver
weight are reported in Table 2. Two animals of the DM day
10 group did not become diabetic (glycemia ,250 mg/dL)
and were excluded, and three animals of the DM day 30
group died before the end of the experimental period. In
contrast to normal controls, which gained weight during the
experimental period, all the diabetic rats showed a
progressive and significant loss of body weight. In the
controls, glycemia was maintained in the normal range
during the entire experimental period, but in the diabetic
rats glycemia, as well as urine volume, were very high on
days 10 and 30. Significant albuminuria (evaluated by two
different methods) appeared only on day 30. Liver weight
did not vary in the diabetic rats, compared with the controls,
but liver/body weight increased on day 30.
Activity of liver proteases
The kinetics of formation of fluorescent product (MCA)
from two different substrates [Z-FR-MCA and e-NH2-
caproyl-Cys(Bzl)-Cys(Bzl)-MCA] is shown in Figure 1. The
kinetics was measured in the presence and absence of
the inhibitors PMSF, E64, and CA074, which inhibit serine
proteases, cysteine proteases, and cathepsin B, respec-
tively. PMSF had no effect on enzymatic activities of the
substrates used here. In contrast, enzyme activities were
very low in the presence of E64, indicating that cysteine
proteases were the main enzymes acting on the substrates.
Z-FR-MCA was the substrate for cathepsin B and also for
other cysteine proteases, while e-NH2-caproyl-Cys(Bzl)-
Cys(Bzl)-MCA was the substrate mainly for cathepsin B
(inhibited by CA074).
Cathepsin B corresponds to about one-half of total
cysteine proteases in rat liver, both normal and diabetic
(Figure 2), and all cysteine protease activities were
decreased in the diabetic liver compared with normal
activity, on both the 10th and 30th days.
Activities of glycosidases and sulfatase
In contrast to the proteases, only the specific activity of
b-D-glucuronidasewas decreased, and only on the 10th day
of STZ-DM (Figure 3). The specific activities of N-acetyl-b-
D-glucosaminidase and N-acetyl-b-D-galactosaminidase
Table 2. Body and liver weights, and glycemia of rats 10 and 30 days after streptozotocin-induced diabetes mellitus (DM) and their
matched controls.
10 Days 30 days
Control (n=13) DM (n=11) Control (n=13) DM (n=10)
Body weight (g)
Initial 307 ± 15 313 ± 33 300 ± 22 326 ± 28
Final 326 ± 19 282 ± 32* 325 ± 19 247 ± 6*
Glycemia (mg/dL)
Initial 105 ± 9 111 ± 13 108 ± 13 111 ± 10
Final 116 ± 28 461 ± 108* 108 ± 21 456 ± 81*
24-h urine volume (mL) 9.1 ± 1.2 97.0 ± 8.4* 8.0 ± 2.1 84.6 ± 11.9*
Urinary albumin (mg/24 h)
RID 0.66 ± 0.36 0.89 ± 0.19 0.48 ± 0.23 2.70 ± 1.85*
ELISA 1.67 ± 0.94 2.03 ± 0.60 1.31 ± 0.70 7.78 ± 2.95**
Liver weight (g) 8.9 ± 0.7 10.3 ± 1.5 9.9 ± 0.7 9.3 ± 1.3
Liver/body weight (610-2) 2.81 ± 0.33 3.35 ± 0.24 3.33 ± 0.20 3.79 ± 0.10*
Data are reported as means±SD. RID: radial immunodiffusion assay. * P,0.05 DM vs matched control (t-test). ** P,0.01 vs matched
control (t-test).
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did not vary in the diabetic liver, compared with normal
activity. Decreased specific activity of sulfatases was
observed only on the 30th day of DM.
Liver expression (mRNA) of cathepsin B, cathepsin L,
and b-D-glucuronidase (qPCR)
The expression of three lysosomal enzymes (cathep-
sin B, cathepsin L, and b-D-glucuronidase) was analyzed
by qPCR in normal and diabetic rat liver. The results are
reported as 2–DDCT relative to the two housekeeping
genes, RPS29 and ACTB (Figure 4).
Figure 1. Kinetics of cysteine protease activities in diabetic (DM)
and normal (NL) rat livers. Tissue extracts (2-6 mL containing
50 mg protein) were preactivated by incubation of tissue extract
aliquots with 2 mM dithiothreitol (10 min, room temperature). The
following substrates were then added (20 mM, 200 mL final
volume): Z-FR-MCA (substrate for cysteine proteases), or e-
NH2-caproyl-Cys(Bzl)-Cys(Bzl)-MCA (substrate for cathepsin B).
The fluorescence produced upon hydrolysis of the substrates
was measured every 20 s in FlexStation 3 (Molecular Devices,
USA), using lexc=380 nm and lemi=460 nm. The assays were
also performed in the presence of inhibitors: 1 mM phenylmethyl-
sulfonyl fluoride (PMSF, inhibitor of serine-proteases), 5 mM E64
(irreversible inhibitor of cysteine-proteases), and 1 mM CA074
(irreversible inhibitor of cathepsin B). A maximum of 10%
substrate consumption was considered, and each point repre-
sents the mean±95% confidence interval of four replicates for all
animals in each group.
Figure 2. Specific activities of cysteine proteases in diabetic (DM)
and normal (NL) rat livers. The assays were performed as
described in Figure 1, except that specific activities are shown
(enzyme units/mg protein, U/mg). The following substrates were
used: Z-FR-MCA (substrate for cysteine proteases), or e-NH2-
caproyl-Cys(Bzl)-Cys(Bzl)-MCA (substrate for cathepsin B). One
enzyme unit was defined as the amount of enzyme that produces
1 nmol product/min. Data are reported as means±SD. Statistically
significant differences between NL and DM are reported as P,0.05
(ANOVA).
Figure 3. Specific activities of glycosidases and sulfatases in
diabetic (DM) and normal (NL) rat livers. Tissue extracts (1-14 mL
containing 20-120 mg protein) were incubated with p-nitrophenyl
monosaccharides or p-nitrophenyl sulfate. One enzyme unit (U)
was defined as the amount of enzyme that produces 1 nmol
product/min. Data are reported as means±SD. Statistically
significant differences between NL and DM are reported as
P,0.05 (ANOVA).
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The relative expression of the two housekeeping
genes used here did not vary on the 10th day of DM
compared with controls, indicating that both can be used
as reference. Nevertheless, on the 30th day, the expres-
sion of ACTB decreased (relative to RPS29) or RPS29
increased (relative to ACTB) in DM (Figure 4), indicat-
ing that at least one of them is not a good reference
gene.
On the 10th day of DM, relative to ACTB, expression of
the three enzymes decreased, whereas, relative to
RPS29, only the expression of cathepsin B decreased.
In contrast, on the 30th day, relative to ACTB, the
expression of cathepsin B and b-D-glucuronidase
increased, whereas, relative to RPS29, they did not vary.
It is possible that the observed increase in expression of
cathepsin B and b-D-glucuronidase relative to ACTB is
only apparent, since ACTB decreased relative to RPS29.
Furthermore, this apparent increase does not correlate to
the specific activities of the enzymes (see Figures 2 and
3), suggesting that, in the diabetic liver, RPS29 is a better
housekeeping gene than ACTB.
Histology, immunohistochemistry, and Western
blotting
No changes were observed in the general histological
organization of the tissue (Figure 5). Figure 6 shows that,
upon toluidine blue staining, metachromatic cells
appeared both in normal and diabetic liver (perivascular),
and cytoplasmatic granules appeared in all hepatocytes,
both normal and diabetic. Tiny granules were also stained
by immunohistochemistry for cathepsin B (Figure 7). The
specificity of the antibodies was analyzed by Western
blotting, which revealed the expected bands of pro-
cathepsin B (,40 kDa) and native cathepsin B (26 and
30 kDa).
Discussion
Although much of the pioneering research on autoph-
agy comes from studies in liver, and lysosomes were
first described in liver (9), there are few studies on the
expression and activities of lysosomal enzymes that act
upon protein and sulfated polysaccharides in the diabetic
liver. In 1974, Amherdt et al. (24) reported an increase in
hepatic lysosome volume in severe diabetes induced by
100 mg/kg STZ, primarily due to autophagosomes. In
1978, Dice et al. (25) showed that the degradation of
proteins is accelerated in the liver of insulin-deficient rats,
and, in 1988, Jorda´ et al. (26) reported a decrease in the
half-life of liver mitochondrial ATPase in the severe
diabetic state, possibly associated with hepatic autoph-
agy. These data indicate that the liver autophagy pathway
seems to be implicated in diabetic complications. Never-
theless, the activities and expression of lysosomal
enzymes were not measured.
Figure 4. Expression (mRNA) of cathepsin B, cathepsin L, and
b-D-glucuronidase in diabetic (DM) and normal (NL) rat livers.
The expression of mRNA was normalized either by ribosomal
protein S29 (RPS29) or b-actin (ACTB). Data are reported as
means±SD. Statistically significant differences between NL and
DM are reported as P,0.05 (ANOVA).
Figure 5. Optical microscopy of diabetic (DM) and normal (NL) rat
livers. Tissue samples from normal and diabetic livers (10 and 30
days of diabetes) were included in paraffin, cut into 4-mm sections,
and stained with hematoxylin and eosin. No significant changes in
liver morphology were observed. Magnification bar: 100 mm.
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In this article, we report a significant decrease in the
specific activities of cysteine proteases, especially cathep-
sin B, in the liver of rats with STZ-DM, on the 10th and 30th
days of the disease. The decrease in liver cysteine protease
activities was much greater than that of kidney (liver: 50-
60% decrease; kidney: 11-15% decrease, see Ref. 5 for
comparison), although in liver the specific activities of these
enzymes were much lower (liver: 2.3-2.7 U/mg, Figure 2;
kidney: 12.5-14.1 U/mg) (5). Decreases in the expressions
(mRNA) of cathepsin B and cathepsin L were also observed
on the 10th day after DM induction, suggesting that the
lower gene expression may be one of the mechanisms
responsible for the lower enzyme activities.
Conversely, the picture concerning sulfated polysac-
charides was very different. The specific activities of most
glycosidaseswere higher in liver than in kidney (5) as follows:
b-D-glucuronidase, liver: 10.2-11.5, kidney: 2.6-3.1 U/mg;N-
acetyl-b-D-glucosaminidase, liver: 7.7, kidney: 3.5-3.9 U/mg;
N-acetyl-b-D-galactosaminidase, liver: 1.1-1.5, kidney:
2.2-2.5 U/mg. Nevertheless, in contrast to kidney, most
activities did not vary in STZ-DM relative to control. A
transitory and slight decrease in the expression and activity
of b-D-glucuronidase (8%)was observed only on the 10th day
of diabetes, while the activities of N-acetyl-b-D-glucosamini-
dase and N-acetyl-b-D-galactosaminidase did not vary.
It is noteworthy that the specific activity of liver
sulfatase was found to have decreased 30% on the 30th
day after DM induction. This decrease could be respon-
sible for the previously reported accumulation of dextran
sulfate in the diabetic liver (2), since the action of
sulfatases precedes the action of glycosidases in the
digestive pathway of sulfated polysaccharides (27).
Figure 6. Optical microscopy of diabetic (DM) and normal (NL)
rat livers. The experiment was performed as described in Figure
5, except that the liver sections were stained by toluidine blue.
Note the metachromatic cells around vessels (arrowheads), and
the cytoplasmatic granules (arrows) in hepatocytes.
Figure 7. Western blotting and immunohistochemistry of ca-
thepsin B in diabetic (DM) and normal (NL) rat livers. A, Tissue
extracts (1.5-2.5 mL containing 30 mg protein) were submitted to
SDS-PAGE (12% acrylamide with 0.32% bisacrylamide for
cathepsin B; 7.5% acrylamide with 0.2% bisacrylamide for b-
actin). Proteins were transferred to nitrocellulose membranes for
Western blotting, and probed with either rabbit polyclonal anti-
cathepsin B or rabbit monoclonal anti-b-actin antibody. Specific
bands were detected by secondary antibody (anti-rabbit IgG)
conjugated with horseradish peroxidase (HRP) and ECL sub-
strate. Images were obtained with the MF-ChemiBIS gel
documentation system. Each lane represents a pool of 4 animals
of each group. B, Tissue sections were incubated with primary
rabbit polyclonal anti-cathepsin B antibody. Controls were
incubated with blocking solution, without any primary antibody.
Anti-rabbit IgG conjugated with HRP was used as secondary
antibody, and nickel enhanced diaminobenzidine was used as
HRP substrate. Tissues were counterstained with hematoxylin.
Cathepsin B-containing structures are brownish, while hematox-
ylin-stained nuclei are purple. Magnification bars: 20 mm.
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There were no apparent changes in liver morphology,
suggesting that the observed effects on lysosomal
proteases and sulfatases were not a consequence of
STZ toxicity. Immunohistochemistry for cathepsin B
showed cytoplasmatic granules in hepatocytes, corrobor-
ating the lysosomal location for these enzymes. The
specificity of the antibodies was confirmed by Western
blotting, which revealed the presence of the expected
bands. Toluidine blue staining also showed cytoplasmatic
granules in hepatocytes, both in normal and diabetic liver.
Taken together, our results suggest that STZ-DM
leads to decreased cathepsin and sulfatase activities in
liver. It seems that this decrease is not a consequence of
general lysosome failure, since the activities of glycosi-
dases did not concurrently decrease in the diabetic liver.
Also, it is not a consequence of general STZ liver toxicity,
since no histological changes were visible.
Degradation of sulfated polysaccharides is usually
initiated by endoglycosidases (matrix or lysosomal), which
produce sulfated poly- and oligosaccharides as products,
and these are the substrates for sulfatases. Only
desulfated products are susceptible to the action of
exoglycosidases that remove specific sugars, one by
one, from the nonreducing end of the molecule. If one of
these lysosomal enzymes is reduced (or absent), partially
degraded molecules accumulate in lysosomes, and may
impair cell function. Stuffed lysosomes may appear as
cytoplasmatic granules in histological analysis, especially
with toluidine blue staining.
The decrease in sulfatase activity observed in the
present study explains the previously reported (2) dextran
sulfate build-up in the diabetic liver.
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